| Dr Shelby Ross Hahn, MD | |
|
3800 S National Ave Ste 700, Springfield, MO 65807-5279 | |
| (417) 269-8817 | |
| (417) 269-8744 |
| Full Name | Dr Shelby Ross Hahn |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 17 Years |
| Location | 3800 S National Ave Ste 700, Springfield, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881875771 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2007016067 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cox Medical Centers | Springfield, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lester E Cox Medical Centers | 1254248917 | 262 |
News Archive
In this week's PLoS Medicine, Abdullah Baqui from the Johns Hopkins Bloomberg School of Public Health, USA and colleagues systematically review studies describing newborn care-seeking behaviours by caregivers in low- and middle-income countries.
Administering high-doses of interleukin-2 (IL-2) has been the preferred treatment for patients with stage IV metastatic melanoma. An article published in the current issue of Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc., explores whether or not this regimen is still the most effective.
Open-access research into drug discovery has arrived in South America, with a ground-breaking collaboration between leading scientists in North America, Europe and Brazil to provide completely free and open research results to the world.
Researchers addressed the question of using reporter particles pseudotyped with the S protein of SARS-CoV-2, which are suitable tools to examine SARS-CoV-2 neutralization antibodies.
The paper describes a national cohort study including all children in Scotland between the ages of 5 and 17 years who were part of the Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II).
› Verified 2 days ago
| Entity Name | Advocates For A Healthy Community Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558303057 PECOS PAC ID: 5395653562 Enrollment ID: O20041109000631 |
News Archive
In this week's PLoS Medicine, Abdullah Baqui from the Johns Hopkins Bloomberg School of Public Health, USA and colleagues systematically review studies describing newborn care-seeking behaviours by caregivers in low- and middle-income countries.
Administering high-doses of interleukin-2 (IL-2) has been the preferred treatment for patients with stage IV metastatic melanoma. An article published in the current issue of Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc., explores whether or not this regimen is still the most effective.
Open-access research into drug discovery has arrived in South America, with a ground-breaking collaboration between leading scientists in North America, Europe and Brazil to provide completely free and open research results to the world.
Researchers addressed the question of using reporter particles pseudotyped with the S protein of SARS-CoV-2, which are suitable tools to examine SARS-CoV-2 neutralization antibodies.
The paper describes a national cohort study including all children in Scotland between the ages of 5 and 17 years who were part of the Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II).
› Verified 2 days ago
| Entity Name | Lester E Cox Medical Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538334396 PECOS PAC ID: 1254248917 Enrollment ID: O20050624000293 |
News Archive
In this week's PLoS Medicine, Abdullah Baqui from the Johns Hopkins Bloomberg School of Public Health, USA and colleagues systematically review studies describing newborn care-seeking behaviours by caregivers in low- and middle-income countries.
Administering high-doses of interleukin-2 (IL-2) has been the preferred treatment for patients with stage IV metastatic melanoma. An article published in the current issue of Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc., explores whether or not this regimen is still the most effective.
Open-access research into drug discovery has arrived in South America, with a ground-breaking collaboration between leading scientists in North America, Europe and Brazil to provide completely free and open research results to the world.
Researchers addressed the question of using reporter particles pseudotyped with the S protein of SARS-CoV-2, which are suitable tools to examine SARS-CoV-2 neutralization antibodies.
The paper describes a national cohort study including all children in Scotland between the ages of 5 and 17 years who were part of the Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II).
› Verified 2 days ago
| Entity Name | Cox Hps Of The Ozarks, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093366999 PECOS PAC ID: 9032237607 Enrollment ID: O20191112002157 |
News Archive
In this week's PLoS Medicine, Abdullah Baqui from the Johns Hopkins Bloomberg School of Public Health, USA and colleagues systematically review studies describing newborn care-seeking behaviours by caregivers in low- and middle-income countries.
Administering high-doses of interleukin-2 (IL-2) has been the preferred treatment for patients with stage IV metastatic melanoma. An article published in the current issue of Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc., explores whether or not this regimen is still the most effective.
Open-access research into drug discovery has arrived in South America, with a ground-breaking collaboration between leading scientists in North America, Europe and Brazil to provide completely free and open research results to the world.
Researchers addressed the question of using reporter particles pseudotyped with the S protein of SARS-CoV-2, which are suitable tools to examine SARS-CoV-2 neutralization antibodies.
The paper describes a national cohort study including all children in Scotland between the ages of 5 and 17 years who were part of the Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shelby Ross Hahn, MD Po Box 4046, Springfield, MO 65808-4046 Ph: (417) 269-5712 | Dr Shelby Ross Hahn, MD 3800 S National Ave Ste 700, Springfield, MO 65807-5279 Ph: (417) 269-8817 |
News Archive
In this week's PLoS Medicine, Abdullah Baqui from the Johns Hopkins Bloomberg School of Public Health, USA and colleagues systematically review studies describing newborn care-seeking behaviours by caregivers in low- and middle-income countries.
Administering high-doses of interleukin-2 (IL-2) has been the preferred treatment for patients with stage IV metastatic melanoma. An article published in the current issue of Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc., explores whether or not this regimen is still the most effective.
Open-access research into drug discovery has arrived in South America, with a ground-breaking collaboration between leading scientists in North America, Europe and Brazil to provide completely free and open research results to the world.
Researchers addressed the question of using reporter particles pseudotyped with the S protein of SARS-CoV-2, which are suitable tools to examine SARS-CoV-2 neutralization antibodies.
The paper describes a national cohort study including all children in Scotland between the ages of 5 and 17 years who were part of the Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II).
› Verified 2 days ago
Shalvinder Kaur Seehra, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3525 E Battlefield St, Springfield, MO 65809 Phone: 417-269-1499 Fax: 417-269-1459 | |
Harwinder K Dhanoa, Family Medicine Medicare: Medicare Enrolled Practice Location: 1540 E Evergreen St, Springfield, MO 65803 Phone: 417-823-2900 | |
Thomas E Dahlberg, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3322 S Campbell Ave Ste T-1, Springfield, MO 65807 Phone: 417-220-4480 Fax: 417-414-0017 | |
Dr. John H Brown, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3231 S National Ave, Suite 280, Springfield, MO 65807 Phone: 417-885-0834 Fax: 417-888-6763 | |
Dr. Jay L Sparks, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3231 S National Ave, Suite 220, Springfield, MO 65807 Phone: 417-820-7450 Fax: 417-820-7455 | |
Dr. Conrad Mitchell Bajor, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 1235 E Cherokee St, Springfield, MO 65804 Phone: 417-820-2600 | |
Dr. William Russell Detten, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1530 E Republic Rd, Springfield, MO 65804 Phone: 417-269-1362 Fax: 417-269-1372 |